Literature DB >> 15996052

The proteasome and its implications in rheumatology.

Ines Colmegna, Bruno Sainz, Robert F Garry, Luis R Espinoza.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15996052

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  2 in total

1.  PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.

Authors:  E-L Paukkeri; T Leppänen; O Sareila; K Vuolteenaho; H Kankaanranta; E Moilanen
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

2.  Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors.

Authors:  Sue Ellen Verbrugge; Marjon Al; Yehuda G Assaraf; Denise Niewerth; Johan van Meerloo; Jacqueline Cloos; Michael van der Veer; George L Scheffer; Godefridus J Peters; Elena T Chan; Janet L Anderl; Christopher J Kirk; Sonja Zweegman; Ben Ac Dijkmans; Willem F Lems; Rik J Scheper; Tanja D de Gruijl; Gerrit Jansen
Journal:  Exp Hematol Oncol       Date:  2013-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.